ÂÜÀòÂÒÂ×

Dr. Jordan Dubow joined LEXEO Therapeutics as Head of CNS Clinical Development in Q1 2023. Dr. Dubow is a neurologist with fellowship training in movement disorders and vascular neurology and began his medical career in academia as a movement disorders and stroke neurologist. Dr. Dubow has extensive experience in the pharmaceutical and biotech industry, where he has served in full time or acting CMO capacities for both public and private companies, leading all clinical and regulatory aspects of development for small and large molecule drugs and cell and gene therapies. Dr. Dubow received his medical degree from the Northwestern University Feinberg School of Medicine. He completed his internal medicine internship, Neurology residency and fellowship training at University of California Los Angeles, Northwestern University and Weill Cornell Medical College.